The variant affects gene HRAS, LRRC56 (HRas proto-oncogene, GTPase| leucine rich repeat containing 56), which is on Chromosome 11. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; HRAS-related disorder